Cargando…
FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas
Ovarian cancer (OC) is a leading cause of cancer mortality, but aside from a few well-studied mutations, very little is known about its underlying causes. As such, we performed survival analysis on ovarian copy number amplifications and gene expression datasets presented by The Cancer Genome Atlas i...
Autores principales: | Raman, Pichai, Purwin, Timothy, Pestell, Richard, Tozeren, Aydin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603440/ https://www.ncbi.nlm.nih.gov/pubmed/26494976 http://dx.doi.org/10.4137/CIN.S30565 |
Ejemplares similares
-
FXYD3 Expression Predicts Poor Prognosis in Renal Cell Carcinoma with Immunosuppressive Tumor Microenvironment
por: Yonekura, Satoru, et al.
Publicado: (2022) -
Pancreatic cancer survival analysis defines a signature that predicts outcome
por: Raman, Pichai, et al.
Publicado: (2018) -
Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma
por: Zhang, Zedan, et al.
Publicado: (2022) -
What FXYDs fix
por: Habeck, Michael, et al.
Publicado: (2021) -
FXYD3: A Promising Biomarker for Urothelial Carcinoma
por: Zhang, ZhongFa, et al.
Publicado: (2011)